Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Distribution and dosimetry of In-111 labeled leukocytes and platelets in humans

Conference · · HHS Publ. (FDA) (U.S.); (United States)
OSTI ID:5919838
 [1]; ;
  1. Veterans Administration Medical Center, Palo Alto, CA
The distribution of In-111 labeled leukocytes and platelets was studied by whole body gamma camera imaging in patients. Images were made approximately one hour and 24 hours after IV injection, and stored in digital form in computer memory. Estimates of the quantitative organ distribution were made from the geometric mean of the anterior and posterior region of interest counts after suitable background subtraction. Nearly quantitative retention of cell activity was observed with little or no excretion seen in either gut or kidneys. Mixed leukocytes distributed in spleen, liver and bone marrow in decreasing order of concentration, similar at both times, with a transient lung uptake noted at the one hour time only. The dose from 0.5 mCi In-111-WBC's was: liver, 1.4 rad; spleen, 8.5 rad; marrow, 2.3 rad. Lymphocytes had similar distribution with the addition of inguinal and cervical lymph nodes. The dose from 0.5 mCi In-111-lymphocytes was: liver, 0.8 rad; spleen, 6.7 rad; marrow and lymphatic tissue, 1.4 rad. Platelets distributed primarily in the blood pool with most of the remainder concentrating in the spleen, with a small amount in the penis. The dose from 0.5 mCi of In-111-platelets was: liver, 3.2 rad; spleen, 8.6 rad; and whole body, 0.3 rad.
OSTI ID:
5919838
Report Number(s):
CONF-801082-
Conference Information:
Journal Name: HHS Publ. (FDA) (U.S.); (United States) Journal Volume: 81-8166
Country of Publication:
United States
Language:
English